Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone regeneration.
KURN | SW
Overview
Corporate Details
- ISIN(s):
- CH0325814116
- LEI:
- 5299006U5POB2AVTT709
- Country:
- Switzerland
- Address:
- Wagisstraße 25, 8952 Schlieren
- Website:
- https://kurosbio.com/
- Sector:
- Manufacturing
Description
Kuros Biosciences is a life sciences company that discovers, develops, and delivers innovative biologic technologies focused on tissue repair and bone regeneration. The company's mission is to address unmet clinical needs for safer, faster, and more predictable bone healing. Its primary commercial product is MagnetOs, an advanced bone graft designed to enhance bone formation. The efficacy of MagnetOs is supported by a comprehensive global research program, "Project Fusion," which includes scientific, pre-clinical, and Level I human clinical studies. Kuros Biosciences serves surgeons and patients across multiple medical fields, including spine, extremities, trauma, and oncology, leveraging deep scientific expertise and collaboration with leading clinical experts.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2015-06-08 07:00 |
Cytos Biotechnology AG invites to the Annual General Meeting
|
English | 6.0 KB | ||
| 2015-05-08 15:46 |
Cytos Biotechnology AG: bond conversion into equity effective
|
English | 5.2 KB | ||
| 2015-05-04 07:00 |
Cytos Biotechnology AG will become debt-free
|
English | 4.9 KB | ||
| 2015-04-28 07:00 |
Cytos Biotechnology Ltd Reports the Financial Results of 2014
|
English | 8.2 KB | ||
| 2015-04-13 07:00 |
Cytos Biotechnology AG: Extension of convertible bond listing at SIX Swiss Exch…
|
English | 4.3 KB | ||
| 2015-03-25 07:00 |
Cytos Biotechnology AG: Novartis buys out CAD 106 license agreement for CHF 4 m…
|
English | 6.1 KB | ||
| 2015-03-16 11:12 |
Cytos Biotechnology AG: Extraordinary Shareholders' Meeting approves all resolu…
|
English | 6.4 KB | ||
| 2015-03-13 07:00 |
Cytos Biotechnology AG: The Higher Court of the Canton of Zurich approves the c…
|
English | 6.8 KB | ||
| 2015-02-19 07:00 |
Cytos Biotechnology AG: Invitation for an Extraordinary Shareholders' Meeting
|
English | 6.3 KB | ||
| 2015-01-26 14:23 |
Cytos Biotechnology AG: Bondholders' meeting approves conversion of bonds into …
|
English | 6.8 KB | ||
| 2015-01-26 07:00 |
Cytos Biotechnology AG: Trading of Cytos shares and convertible bonds temporari…
|
English | 6.2 KB | ||
| 2015-01-06 07:00 |
Cytos Biotechnology AG exclusively licenses its VLP platform for the treatment …
|
English | 9.7 KB | ||
| 2014-10-27 18:00 |
Cytos Biotechnology Ltd announces change in Executive Board
|
English | 3.8 KB | ||
| 2014-09-30 07:00 |
Cytos Biotechnology Ltd reports the financial results of the First Half Year 20…
|
English | 5.4 KB | ||
| 2014-05-05 07:00 |
Cytos Biotechnology Ltd to wind down Key Operational Activities
|
English | 5.1 KB |
Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kuros Biosciences Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-23 | N/A | Executive member | Sell | None | 1,264,800.00 CHF |
| 2025-04-17 | N/A | Executive member | Sell | None | 13,344.49 CHF |
| 2025-03-18 | N/A | Non-Executive member | Buy | None | 38,200.00 CHF |
| 2024-12-11 | N/A | Executive member | Sell | None | 4,702,500.00 CHF |
| 2024-11-15 | N/A | Non-Executive member | Buy | None | 925,210.00 CHF |
| 2024-11-14 | N/A | Non-Executive member | Sell | None | 592,000.00 CHF |
| 2024-11-12 | N/A | Executive member | Sell | None | 13,890.86 CHF |
| 2024-09-25 | N/A | Executive member | Sell | None | 8,226,000.00 CHF |
| 2024-09-25 | N/A | Non-Executive member | Sell | None | 3,656,000.00 CHF |
| 2024-09-24 | N/A | Non-Executive member | Buy | None | 223,720.00 CHF |
Peer Companies
